MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease

K. Tosefsky, Y. Wang, A. Kuan, V. Ngo, C. Agu, D. Liang, L. Liu, O. Geiger, S. Keymanesh, M. Sacheli, E. Gerson, S. Cresswell (Vancouver, Canada)

Meeting: 2024 International Congress

Abstract Number: 501

Keywords: Gastrointestinal problemsm(also see autonomic dysfunction), Lipid metabolism, Parkinson’s

Category: Parkinson’s Disease: Clinical Trials

Objective:

​​​To assess the feasibility of combining Mediterranean and ketogenic dietary principles in persons with Parkinson’s disease (PwP).

Background: Dietary interventions have been proposed as adjunct self-management strategies for persons with Parkinson’s disease (PwP). While Mediterranean-style diets may alleviate PD-associated gut dysbiosis, ketogenic diets may help circumvent disease-linked deficits in brain glucose metabolism. Studies have yet to assess the potential benefits of combining Mediterranean and ketogenic dietary principles in PwP.

Method: In this ongoing crossover study (NCT05469997), participants with PD follow two 8-week dietary interventions, separated by an 8-week washout: 1) a high-fat, low-carbohydrate Mediterranean diet (MEDI-KD) and 2) a standard Mediterranean diet supplemented with medium chain triglycerides (MEDI-MCT). Participants are recruited on a rolling basis from a tertiary center in Vancouver, Canada. Interim feasibility analysis was performed based on study retention rates, weekly blood ketone monitoring and qualitative analysis of post-intervention participant interviews.

Results: 48 of a target 50 participants attended first study visits, of which 45 (94%) started the first diet to which they were randomized. Five (10%) participants withdrew, and one was lost to follow-up (2%), before completing the first intervention phase, while another three (6%) withdrew before completing the second phase. Reasons for withdrawal from the MEDI-KD phase included social limitations (1/4), gastroparesis leading to increased OFF time (1/4), socioeconomic (1/4) and time (1/4) constraints. Reasons for withdrawal from the MEDI-MCT phase included tremor exacerbation (1/4), diarrhea (1/4), time constraints (1/4) and a disabling injury (1/4). The mean blood ketone level in the MEDI-KD and MEDI-MCT phases were 0.42 (SD: 0.28; n = 22) mM and 0.27 (SD: 0.18; n = 19) mM, respectively. During interviews, positive reflections centered on professional nutritional guidance, increased dietary mindfulness and Mediterranean-style cuisine. Negative sentiments were focused on the restrictive nature and social impracticability of the ketogenic diet, as well as the gastrointestinal side effects of MCT oil.

Conclusion: While Mediterranean-style diets appear to be well-received among PwP, interim trial results suggest several barriers to their combination with ketogenic-style interventions.

To cite this abstract in AMA style:

K. Tosefsky, Y. Wang, A. Kuan, V. Ngo, C. Agu, D. Liang, L. Liu, O. Geiger, S. Keymanesh, M. Sacheli, E. Gerson, S. Cresswell. Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/interim-analysis-of-the-feasibility-of-mediterranean-ketogenic-dietary-interventions-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/interim-analysis-of-the-feasibility-of-mediterranean-ketogenic-dietary-interventions-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley